Cargando…
Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study
BACKGROUND: Virological response to peginterferon + ribavirin (P+R) at week 4 can predict sustained virological response (SVR). While patients with rapid virological response (RVR) do not require triple therapy, patients with a decline <1log(10) IU/ml HCVRNA (D1L) should have treatment discontinu...
Autores principales: | Romero-Gómez, Manuel, Turnes, Juan, Ampuero, Javier, Oyagüez, Itziar, Cuenca, Beatriz, Gonzalez-Garcia, Juan, Muñoz-Molina, Belén, Aguilar, Rocio, Leal, Sandra, Planas, Ramon, Garcia-Samaniego, Javier, Diago, Moises, Crespo, Javier, Calleja, Jose Luis, Casado, Miguel Angel, Sola, Ricard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426774/ https://www.ncbi.nlm.nih.gov/pubmed/25826755 http://dx.doi.org/10.1371/journal.pone.0122613 |
Ejemplares similares
-
Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.
por: Sempere, Elena Diago, et al.
Publicado: (2022) -
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
por: García-Ruiz, Antonio J, et al.
Publicado: (2012) -
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
por: Calleja, Miguel Angel, et al.
Publicado: (2023) -
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review
por: Picchio, Camila A., et al.
Publicado: (2021) -
Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world
por: Crespo, Javier, et al.
Publicado: (2021)